RARA CRAFT DATABASE for FDA Medical Devices
510(k)K153316

FDA DEVICE FACTS

Cardinal Health Sterile Neoprene Powder-Free Surgical Gloves with Nitrile Coating and Tested for Use with Chemotherapy Drugs (Yellow)

Cardinal Health, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 12, 2016PRODUCT CODEKGO

Indications for use

A powder-free sterile surgeon's glove is a disposable device made of synthetic rubber intended to be worn by operating room personnel to protect a surgical wound from contamination. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs: Minimum Breakthrough Detection Time, Chemotherapy Drug and Concentration 0.01 pg/cm?/minute

1. | Carmustine (BCNU) (3.3 mg/ml) 60.1

2. | Cisplastin, (1.0 mg/ml) >240 3._| Cyclophosphamide (20 mg/ml) >240

4. | Doxorubicin HCl (2.0 mg/ml) >240

5. | Etoposide (Toposar) (20 mg/ml) >240

6. | Fluorouracil (50 mg/ml) >240 7._| Methotrexate (25 mg/ml) >240

8. | Mitomycin C (0.5 mg/ml) >240

9. | Paclitaxel (Taxol) (6.0 mg/ml) >240

10. | Thiotepa (10 mg/ml) 110.5

11. | Vincristine Sulfate(1 mg/ml) >240 CAUTION: Testing showed an average breakthrough time of 60.1 minutes with Carmustine

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 3, 2026